to explore results)
- Epigenetics for Drug Discovery, CHAPTER 9 Who will Benefit from Epigenetic Drugs?.
, Pages 230-248
- Metal-based Anticancer Agents, CHAPTER 1 Enhancing the Therapeutic Potential of Platinum-based Anticancer Agents by Incorporating Clinically Approved Drugs as Ligands.
, Pages 1-30
- Anti-aging Drugs: From Basic Research to Clinical Practice, CHAPTER 21 HDAC Inhibitors: A New Avenue in Anti-Aging Medicine.
, Pages 514-534
- Metal-based Anticancer Agents, Subject Index
, Pages 348-355
- Epigenetics for Drug Discovery, CHAPTER 5 Targeting Histone Acetylation.
, Pages 96-126
- Metal-based Anticancer Agents, Contents
, Pages P007-P013
- Nuclear Magnetic Resonance: Volume 42, NMR in living systems.
, Volume 42
, Pages 498-534
- Epigenetics for Drug Discovery, Subject Index
, Pages 316-321
- Designing Multi-Target Drugs, Chapter 14 Discovery of HDAC-Inhibiting Multi-Target Inhibitors.
, Pages 221-242
- Polyamine Drug Discovery, Chapter 10 The Design and Development of Polyamine-Based Analogs with Epigenetic Targets.
, Pages 238-256